BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 2499756)

  • 21. Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility.
    Schild RL; Hoch J; Plath H; Geissen C; Fahnenstich H; Dame C; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Jul; 14(1):64-7. PubMed ID: 10461341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-Rh32 causing severe hemolytic disease of the newborn.
    Orlina AR; Unger PJ; Lacey PA
    Rev Fr Transfus Immunohematol; 1984 Oct; 27(5):613-8. PubMed ID: 6441229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Perinatal hemolytic disease caused by anti-c. A clinical case].
    Donoso Siña E; Herrera Gonzalez B; González Bruzzone P; Cuellar Castañón A
    Rev Chil Obstet Ginecol; 1983; 48(3):175-9. PubMed ID: 6442780
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rh alloimmunization].
    Boda D; Pataki L
    Orv Hetil; 1996 Nov; 137(44):2485. PubMed ID: 9026764
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intrauterine exchange transfusion in cases of iso-immunization].
    Zárate H; Bravo R; Avalos J; Pérez L; Torres B; Rodríguez Argüelles J
    Ginecol Obstet Mex; 1969 Aug; 26(154):221-34. PubMed ID: 4989177
    [No Abstract]   [Full Text] [Related]  

  • 27. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
    Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
    Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antenatal serologic assessment of severity of hemolytic disease due to anti-Rh.
    Frankowska K
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):613-9. PubMed ID: 5006484
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment with immunodepressant drugs in neonatal hemolytic disease caused by Rh isoimmunization (preliminary note)].
    De Luca P; Merlino G
    Arch Ostet Ginecol; 1980; 85(3):169-73. PubMed ID: 6802113
    [No Abstract]   [Full Text] [Related]  

  • 31. [Participation of the I Clinic of Obstetrics and Gynecology, Medical Academy, in Wrocław in the activities of the Center of Immunopathology of Pregnancy. The first exchange transfusion in Poland].
    Heimrath T
    Acta Haematol Pol; 1988; 19(3-4):217-21. PubMed ID: 3150898
    [No Abstract]   [Full Text] [Related]  

  • 32. [Activity of the Center for study of Rh factors of the Clinica Ostetrica e Ginecologica of the University of Naples in the prevention of hemolytic disease of the newborn].
    Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A
    Arch Ostet Ginecol; 1969 Dec; 74(6):461-75. PubMed ID: 5406384
    [No Abstract]   [Full Text] [Related]  

  • 33. Rhesus anti-E, anti-c antibodies as a cause of hemolytic disease of the newborn.
    Nair PM; Sabarinathan K; Jayaprakash PA; Vijayalekshmi
    Indian Pediatr; 1983 Sep; 20(9):681-4. PubMed ID: 6427106
    [No Abstract]   [Full Text] [Related]  

  • 34. Term neonates with hemolytic disease of the newborn and necrotizing enterocolitis: a report of two cases.
    Roig JC; Burchfield DJ
    J Perinatol; 1994; 14(3):201-3. PubMed ID: 8064424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of the amniotic fluid in a severe case of hemolytic disease of the newborn: trial therapy by intra-uterine exchange transfusion].
    Mellone O; Sawaya C
    Rev Hosp Clin Fac Med Sao Paulo; 1965 Sep; 20(5):258-63. PubMed ID: 5852756
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment options for the fetus with alloimmune hemolytic disease.
    Bowman JM
    Transfus Med Rev; 1990 Jul; 4(3):191-207. PubMed ID: 2134630
    [No Abstract]   [Full Text] [Related]  

  • 37. Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation.
    Westgren M; Selbing A; Stangenberg M
    Br Med J (Clin Res Ed); 1988 Mar; 296(6626):885-6. PubMed ID: 3129060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemolytic disease of the newborn due to anti-c.
    Saenz RB
    J Tenn Med Assoc; 1993 Jan; 86(1):9-11. PubMed ID: 8455385
    [No Abstract]   [Full Text] [Related]  

  • 39. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions.
    Saade GR; Moise KJ; Belfort MA; Hesketh DE; Carpenter RJ
    Fetal Diagn Ther; 1993; 8(3):161-4. PubMed ID: 8240686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
    De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
    Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.